Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06PVN
|
|||
Former ID |
DIB015338
|
|||
Drug Name |
R-65
|
|||
Synonyms |
PGN-1473; R-65 (myometrial disorders), Asterand; R-65 (myometrial disorders), Pharmagene
Click to Show/Hide
|
|||
Indication | Glaucoma/ocular hypertension [ICD-11: 9C61; ICD-9: 365] | Investigative | [1] | |
Company |
Pharmagene plc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin E2 receptor EP2 (PTGER2) | Target Info | Modulator | [1] |
KEGG Pathway | cAMP signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Inflammatory mediator regulation of TRP channels | ||||
Renin secretion | ||||
Pathways in cancer | ||||
Reactome | Prostanoid ligand receptors | |||
G alpha (s) signalling events | ||||
WikiPathways | Prostaglandin Synthesis and Regulation | |||
GPCRs, Class A Rhodopsin-like | ||||
Ovarian Infertility Genes | ||||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 341). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.